Yehuda Handelsman, MD, FACP, FNLA, FASPC, MACE is an endocrinologist in private practice and Medical Director & Principal Investigator of the Metabolic Institute of America. He is a nationally and internationally recognized authority on Diabetes, Lipids, Obesity, HTN their management and the prevention of complications- specifically CVD, CHF and CKD. He is Master of American College of Endocrinology, Fellow American Society of Preventive Cardiology, National lipid Association and the American College of Physicians. He chairs AACE/ACE 2020 Lipid management Algorithm, a Member of AACE/ACE 2020 Comprehensive Diabetes Management Algorithm and Combined Guidelines for CGM & Pumps. Past president of American College of Endocrinology, American Association of Clinical Endocrinologists and Pacific Lipid Association. Chair the annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease, The Heart in Diabetes Congress and the International Lipid Forum. He chaired consensuses on SGLT2i & DKA, Diabetes Obesity & Cancer, Insulin Resistance Syndrome, lipodystrophy and Pre-Diabetes. An associate and guest editor of several medical journals He published near 140 peer reviewed original research, practice guidelines, editorials and books’ chapters. His Book “Clinical Management of Cardiovascular Risk in Diabetes and Obesity” is published by Professional Communications, Inc.
What is your favorite Endocrine Society memory?
The 2020 virtual annual meeting
What advice would you give for someone looking to become more involved in the Endocrine Society?
Explore areas of interest and volunteer to contribute
How has the Endocrine Society supported your professional development/career journey?
Kept Endocrinology in center stage and created relevant Clinical Guidelines
What do you like to do in your spare time?
Swim in the Ocean, Travel, Theater Dancing